Dermata Reports $74K in Q3 2026 Sales, Expects Cash Into Q1 2027
Dermata reported a $2.8 million net loss for Q3 2026, compared with $1.7 million a year earlier. Cash, cash equivalents and restricted cash totaled $5.0 million at September 30, 2026, versus $7.5 million at December 31, 2025.
Dermata reported Q3 2026 net sales of $74K, versus none in Q3 2025, and a net loss of $2.8M versus $1.7M. Cash, cash equivalents and restricted cash were $5.0M at September 30, 2026, versus $7.5M at December 31, 2025; the company expects resources to fund operations into Q1 2027.Material DetailsCon…